Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00470704
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2007-05-07
Brief Title:
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive Metastatic Breast Cancer
Sponsor:
Nancy Lin MD
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2007-05-07
First Submit QC Date:
May 7 2007
Study First Post Date:
2007-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-26
Last Update Post Date:
2024-03-27
Last Update Post Date Type:
ACTUAL